CoStar
CSGP
27.60
-0.03
-0.11%
CoStar
US · CSGP
#1375 by market cap
Listed 1970
27.60
-0.03
-0.11%
Live - 5344 symbols - heartbeat 348s ago
· 2026-10-08 04:11
Pre-market
27.23
-1.34%
After-hours
27.72
+0.43%
Overnight
27.74
+0.51%
- Market cap
- 11.18B
- P/E (TTM)i
- 153.33
- P/Bi
- 1.41
- EPSi
- 0.02
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on CSGP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.85, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +18.68% YoY
Margins
- Gross margin
- 78.87%
- Operating margin
- -2.22%
- Net margin
- 0.22%
Key ratios & quality
- Enterprise valuei
- 10.57B
- Altman Z-Scorei
- 3.85
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.40B | 1.66B | 1.94B | 2.18B | 2.46B | 2.74B | 3.25B |
| Gross profit | 921.90M | 1.11B | 1.35B | 1.59B | 1.77B | 1.96B | 2.18B | 2.56B |
| Selling & admin expenses | 516.52M | 587.34M | 835.48M | 878.80M | 1.02B | 1.37B | 1.80B | 2.11B |
| Research & development | 100.94M | 125.60M | 162.92M | 201.00M | 220.90M | 268.00M | 326.00M | 406.00M |
| Operating profit | 273.56M | 363.55M | 289.20M | 432.30M | 451.00M | 282.00M | 5.00M | -72.00M |
| Pretax profit | 284.02M | 390.95M | 270.98M | 404.00M | 486.50M | 502.00M | 210.00M | 30.00M |
| Tax | 45.68M | 75.99M | 43.85M | 111.40M | 117.00M | 127.00M | 71.00M | 23.00M |
| Net profit | 238.33M | 314.96M | 227.13M | 292.60M | 369.50M | 375.00M | 139.00M | 7.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Diluted EPS | 0.65 | 0.86 | 0.59 | 0.74 | 0.93 | 0.92 | 0.34 | 0.02 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 732.00M | 781.00M | 833.60M | 899.90M | 897.00M | 925.00M |
| Gross profit | 579.00M | 613.00M | 661.40M | 707.20M | 701.00M | 728.00M |
| Selling & admin expenses | 510.00M | 517.00M | 575.30M | 506.60M | 547.00M | 509.00M |
| Research & development | 95.00M | 96.00M | 105.40M | 109.00M | 114.00M | 107.00M |
| Operating profit | -43.00M | -27.00M | -51.10M | 49.10M | 3.00M | 76.00M |
| Pretax profit | -7.00M | 22.00M | -45.80M | 60.90M | 12.00M | 74.00M |
| Tax | 8.00M | 16.00M | -14.90M | 14.40M | 9.00M | 19.00M |
| Net profit | -15.00M | 6.00M | -30.90M | 46.50M | 3.00M | 55.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.04 | 0.01 | -0.07 | 0.11 | 0.01 | 0.14 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.21B | 1.20B | 3.89B | 3.99B | 5.19B | 5.48B | 4.95B | 2.12B |
| Cash & ST investments | 1.10B | 1.07B | 3.69B | 3.83B | 4.97B | 5.22B | 4.68B | 1.63B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 3.31B | 3.85B | 6.92B | 7.26B | 8.40B | 8.92B | 9.26B | 10.54B |
| Total current liabilities | 154.16M | 207.06M | 330.85M | 338.69M | 372.70M | 455.80M | 552.00M | 746.00M |
| Short-term debt | -- | 29.67M | 32.65M | 26.27M | 36.00M | 40.00M | 32.00M | 28.00M |
| Long-term debt | -- | -- | 986.72M | 987.94M | 989.20M | 990.50M | 992.00M | 993.00M |
| Total liabilities | 291,015,000.00 | 448,393,000.00 | 1,540,061,000.00 | 1,545,199,000.00 | 1,532,500,000.00 | 1,581,100,000.00 | 1,704,000,000.00 | 2,167,000,000.00 |
| Total equity | 3.02B | 3.41B | 5.38B | 5.71B | 6.87B | 7.34B | 7.55B | 8.37B |
| Retained earnings | 613.45M | 940.47M | 1.17B | 1.46B | 1.83B | 2.20B | 2.34B | 2.35B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.35B | 4.33B | 2.41B | 2.12B | 1.71B | 1.65B |
| Cash & ST investments | 3.97B | 3.94B | 1.94B | 1.63B | 1.22B | 1.27B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 10.43B | 10.51B | 10.82B | 10.54B | 10.16B | 10.14B |
| Total current liabilities | 724.40M | 742.40M | 770.50M | 746.00M | 777.00M | 747.00M |
| Short-term debt | 28.20M | 25.80M | 28.40M | 28.00M | 28.00M | 30.00M |
| Long-term debt | 992.20M | 992.50M | 992.90M | 993.00M | 994.00M | 994.00M |
| Total liabilities | 1,871,900,000.00 | 1,905,700,000.00 | 2,196,000,000.00 | 2,167,000,000.00 | 2,213,000,000.00 | 2,194,000,000.00 |
| Total equity | 8.56B | 8.60B | 8.62B | 8.37B | 7.95B | 7.95B |
| Retained earnings | 2.33B | 2.33B | 2.30B | 2.35B | 2.35B | 2.41B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 335.46M | 457.78M | 486.11M | 469.73M | 478.70M | 490.00M | 393.00M | 430.00M |
| Depreciation & amortization | 77.74M | 81.17M | 116.94M | 139.56M | 137.90M | 108.00M | 147.00M | 263.00M |
| Free cash flow | 305.83M | 411.58M | 437.76M | 404.51M | 384.90M | 347.00M | -245.00M | 41.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 1.69B | 0 | 745.70M | 0 | 0 | -500.00M |
| Ending cash balance | 1.10B | 1.07B | 3.76B | 3.83B | 4.97B | 5.22B | 4.68B | 1.73B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 53.00M | 147.00M | 67.90M | 162.10M | 152.00M | 115.00M |
| Depreciation & amortization | 47.00M | 66.00M | 69.00M | 81.00M | 82.00M | 85.00M |
| Free cash flow | -27.00M | -4.00M | -23.60M | 95.60M | 98.00M | 57.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -19.00M | -45.00M | -51.00M | -385.00M | -505.00M | -82.00M |
| Ending cash balance | 3.78B | 3.73B | 2.03B | 1.73B | 1.32B | 1.27B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.40 | 9.80 | 5.17 | 5.28 | 5.87 | 5.27 | 1.86 | 0.09 |
| ROA %i | 7.71 | 8.79 | 4.22 | 4.13 | 4.72 | 4.33 | 1.53 | 0.07 |
| ROIC %i | 8.09 | 8.67 | 4.50 | 4.38 | 4.99 | 4.56 | 1.62 | -0.88 |
| 5-year avg ROE %i | 4.57 | 5.80 | 6.88 | 6.87 | 6.91 | 6.28 | 4.69 | 3.68 |
| EBIT margin %i | 24.07 | 28.12 | 17.43 | 22.24 | 20.66 | 11.50 | 0.17 | -2.22 |
| FCF / sales %i | 25.66 | 29.40 | 26.39 | 20.81 | 19.25 | 18.91 | -- | 1.26 |
| Current ratioi | 7.87 | 5.79 | 11.75 | 11.78 | 13.91 | 12.01 | 8.97 | 2.84 |
| Quick ratioi | 7.72 | 5.62 | 11.48 | 11.67 | 13.74 | 11.86 | 8.82 | 2.53 |
| Debt / assetsi | 0.12 | 4.24 | 16.54 | 15.46 | 13.16 | 12.45 | 12.43 | 11.24 |
| LT debt / equityi | 0.13 | 3.93 | 20.67 | 19.18 | 15.57 | 14.59 | 14.82 | 13.87 |
| Interest coveragei | 101.36 | 150.50 | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 18.75 | 18.67 | 19.79 | 17.72 | 15.96 | 13.96 | 12.06 | 14.16 |
| Net income CAGR (3Y) %i | -- | 54.70 | 22.79 | 7.08 | 5.47 | 18.19 | -21.97 | -73.34 |
| FCF CAGR (3Y) %i | 42.94 | 31.29 | 27.70 | 9.77 | -2.21 | -7.45 | -- | -52.60 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 1.47 | 1.30 | 0.25 | 0.09 | 0.30 | 0.90 |
| ROA %i | 1.20 | 1.06 | 0.20 | 0.07 | 0.24 | 0.72 |
| ROIC %i | 1.29 | 1.14 | 0.22 | -0.88 | -0.26 | 0.78 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 0.17 | -0.22 | -2.65 | -2.22 | -0.76 | 2.17 |
| FCF / sales %i | -- | -- | -- | 1.26 | 4.87 | 6.38 |
| Current ratioi | 6.01 | 5.83 | 3.12 | 2.84 | 2.20 | 2.21 |
| Quick ratioi | 5.76 | 5.58 | 2.83 | 2.53 | 1.93 | 2.06 |
| Debt / assetsi | 10.95 | 10.99 | 10.89 | 11.24 | 11.71 | 11.86 |
| LT debt / equityi | 13.01 | 13.12 | 13.34 | 13.87 | 14.68 | 14.78 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Commercial Real Estate is the largest reported line at 52.00% of revenue, across 2 reported segments.
- Residential Real Estate follows at 48.00%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Commercial Real Estate52.00%
Residential Real Estate48.00%
Quote time 2026-10-08 04:11:42 · For reference only, not investment advice and not tailored to your situation.